Structure Therapeutics IncNASDAQ:GPCR
- LAST PRICE36.8399
- TODAY'S CHANGE (%)-1.8601 (-4.8065%)
- Bid / Lots36.7300/ 8
- Ask / Lots36.9000/ 8
- Open / Previous Close38.6500 / 38.7000
- Day Range
- 52 Week Range
- Volume345,175
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GPCR |
|---|---|---|
| 09:32 ET | 2854 | 38.655 |
| 09:33 ET | 300 | 38.605 |
| 09:35 ET | 300 | 38.59 |
| 09:37 ET | 200 | 38.59 |
| 09:42 ET | 100 | 38.6 |
| 09:44 ET | 650 | 38.605 |
| 09:46 ET | 2677 | 38.09 |
| 09:48 ET | 1650 | 38.04 |
| 09:50 ET | 230 | 38.3 |
| 09:51 ET | 650 | 38.09 |
| 09:53 ET | 1204 | 38.13 |
| 09:55 ET | 1620 | 38 |
| 09:57 ET | 3065 | 37.845 |
| 10:00 ET | 1400 | 37.72 |
| 10:02 ET | 2550 | 37.815 |
| 10:04 ET | 1040 | 37.81 |
| 10:06 ET | 1100 | 37.825 |
| 10:08 ET | 401 | 37.73 |
| 10:09 ET | 554 | 37.74 |
| 10:11 ET | 1811 | 37.69 |
| 10:13 ET | 1737 | 37.64 |
| 10:15 ET | 3450 | 37.785 |
| 10:18 ET | 464 | 37.7943 |
| 10:20 ET | 2735 | 37.425 |
| 10:22 ET | 588 | 37.384545 |
| 10:24 ET | 480 | 37.4367 |
| 10:27 ET | 1500 | 37.53 |
| 10:29 ET | 1968 | 37.63 |
| 10:31 ET | 400 | 37.66 |
| 10:33 ET | 1980 | 37.65 |
| 10:36 ET | 268 | 37.4491 |
| 10:38 ET | 2944 | 37.14 |
| 10:40 ET | 15735 | 37.315 |
| 10:42 ET | 952 | 37.285 |
| 10:44 ET | 1000 | 37.28 |
| 10:45 ET | 2640 | 37.08 |
| 10:47 ET | 448 | 37.065 |
| 10:49 ET | 1700 | 37.2 |
| 10:51 ET | 200 | 37.155 |
| 10:54 ET | 400 | 37.12 |
| 10:56 ET | 3370 | 36.985 |
| 10:58 ET | 1260 | 36.895 |
| 11:00 ET | 1100 | 36.82 |
| 11:02 ET | 676 | 36.81 |
| 11:03 ET | 300 | 36.86 |
| 11:05 ET | 3275 | 36.75 |
| 11:07 ET | 4853 | 36.61 |
| 11:09 ET | 700 | 36.62 |
| 11:12 ET | 5603 | 36.645 |
| 11:14 ET | 400 | 36.56 |
| 11:16 ET | 400 | 36.5664 |
| 11:18 ET | 7673 | 36.39 |
| 11:20 ET | 575 | 36.32 |
| 11:21 ET | 266 | 36.34 |
| 11:23 ET | 1800 | 36.385 |
| 11:25 ET | 800 | 36.34 |
| 11:27 ET | 11676 | 36.43 |
| 11:30 ET | 3213 | 36.46 |
| 11:32 ET | 525 | 36.47 |
| 11:34 ET | 4004 | 36.29 |
| 11:36 ET | 600 | 36.15 |
| 11:38 ET | 3500 | 36.27 |
| 11:39 ET | 4747 | 36.34 |
| 11:41 ET | 815 | 36.33 |
| 11:43 ET | 1413 | 36.245 |
| 11:45 ET | 5157 | 36.01 |
| 11:48 ET | 4540 | 35.91 |
| 11:50 ET | 2665 | 36.11 |
| 11:52 ET | 480 | 36.045 |
| 11:54 ET | 200 | 36.06 |
| 11:56 ET | 555 | 36.06 |
| 11:57 ET | 1192 | 36.16 |
| 11:59 ET | 300 | 36.12 |
| 12:01 ET | 200 | 36.12 |
| 12:03 ET | 1000 | 36.0219 |
| 12:06 ET | 2793 | 36.11 |
| 12:08 ET | 200 | 36.105 |
| 12:10 ET | 350 | 36.13 |
| 12:12 ET | 300 | 36.15 |
| 12:14 ET | 1000 | 36.05 |
| 12:15 ET | 12214 | 36.365 |
| 12:17 ET | 5748 | 36.42 |
| 12:19 ET | 3329 | 36.48 |
| 12:21 ET | 1200 | 36.525 |
| 12:24 ET | 900 | 36.43 |
| 12:26 ET | 4090 | 36.52 |
| 12:28 ET | 100 | 36.54 |
| 12:30 ET | 1777 | 36.555 |
| 12:32 ET | 9475 | 37.11 |
| 12:33 ET | 1477 | 37.04 |
| 12:35 ET | 1566 | 36.96 |
| 12:37 ET | 1500 | 36.94 |
| 12:39 ET | 3900 | 36.76 |
| 12:42 ET | 5171 | 36.49 |
| 12:44 ET | 650 | 36.535 |
| 12:46 ET | 2251 | 36.425 |
| 12:48 ET | 400 | 36.385 |
| 12:50 ET | 1606 | 36.3 |
| 12:51 ET | 1100 | 36.2 |
| 12:53 ET | 2475 | 36.315 |
| 12:55 ET | 200 | 36.31 |
| 12:57 ET | 400 | 36.2875 |
| 01:00 ET | 400 | 36.29 |
| 01:02 ET | 400 | 36.355 |
| 01:04 ET | 1400 | 36.315 |
| 01:06 ET | 1026 | 36.29 |
| 01:08 ET | 900 | 36.25 |
| 01:09 ET | 1304 | 36.28 |
| 01:11 ET | 700 | 36.32 |
| 01:13 ET | 9367 | 36.655 |
| 01:15 ET | 1600 | 36.555 |
| 01:18 ET | 6318 | 36.44 |
| 01:20 ET | 1121 | 36.5 |
| 01:22 ET | 200 | 36.495 |
| 01:24 ET | 14276 | 36.49 |
| 01:26 ET | 800 | 36.485 |
| 01:27 ET | 500 | 36.48 |
| 01:29 ET | 500 | 36.5 |
| 01:31 ET | 1300 | 36.66 |
| 01:33 ET | 1686 | 37.02 |
| 01:36 ET | 3377 | 36.945 |
| 01:38 ET | 3243 | 36.88 |
| 01:40 ET | 900 | 36.835 |
| 01:42 ET | 450 | 36.82 |
| 01:44 ET | 2900 | 36.73 |
| 01:45 ET | 300 | 36.82 |
Oct 31, 2024
Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek(R) 2024, from 8:30AM ET on Thursday Oct 31, 2024 by Dow Jones
8:30AM ET on Thursday Oct 31, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Structure Therapeutics Inc | 2.2B | -16.5x | --- |
Neumora Therapeutics Inc | 2.2B | -7.0x | --- |
Akero Therapeutics Inc | 2.3B | -9.5x | --- |
Centessa Pharmaceuticals PLC | 2.1B | -11.1x | --- |
Longboard Pharmaceuticals Inc | 2.3B | -26.7x | --- |
NewAmsterdam Pharma Company NV | 2.3B | -10.9x | --- |
Company Information
Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.
Contact Information
- Headquarters
- 611 Gateway Blvd Suite 223SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Daniel Welch
- Chief Executive Officer, Director
- Raymond Stevens
- Chief Financial Officer
- Jun Yoon
- Chief Technology Officer
- Yingli Ma
- Chief Scientific Officer
- Xichen Lin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.2B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 57.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.24 |
Book Value | $9.76 |
P/E Ratio | -16.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
